Combined with the aforementioned results that TCGA-AML patients with high 9-CSMs risk scores exhibited a high activation of the PI3K-AKT signaling pathway, we believe that the 9-CSMs prognostic model may play a role in guiding the selection of chemotherapy drugs for patients. Here, AKT1 is linked to acute myeloid leukemia.